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ABSTRACT 
 
Background: Attention-deficit/hyperactivity disorder (ADHD) is a common 
developmental disorder, often persisting into adulthood. Whilst medication is first-line 
treatment for ADHD, there is a need for evidence-based non-pharmacological 
treatment options for adults with ADHD who are either still experiencing significant 
symptoms or for those who have made the informed choice not to start medication. 
Methods: We systematically searched PsycINFO, MEDLINE (Ovid), EMBASE, 
CINAHL and CENTRAL for randomised controlled trials of non-pharmacological 
treatments for ADHD in adults. After screening of titles and abstracts, full text articles 
were reviewed, data extracted, and bias assessed using a study proforma. Results: 
There were 32 eligible studies with the largest number of studies assessing cognitive 
behavioural therapy (CBT). CBT consisted of either group, internet or individual 
therapy. Conclusions: The majority found an improvement in ADHD symptoms with 
CBT treatment. Additionally, mindfulness and cognitive remediation have evidence as 
effective interventions for the core symptoms of ADHD and there is evidence for the 
use of group dialectical behavioural therapy and hypnotherapy. However, the evidence 
for these is weaker due to small numbers of participants and limitations due to lack of 
suitable control conditions, and a high risk of bias.  
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INTRODUCTION 
 
Attention-deficit/hyperactivity disorder (ADHD), is present in 2-4% of adults and is 
characterised by symptoms of inattention, over activity and impulsiveness (McCarthy 
et al., 2012). Features of ADHD emerge in childhood and symptoms persist into 
adulthood; 60% of adults have ongoing notable ADHD symptoms and 15-20% 
continue to meet the full diagnostic criteria (Agnew-Blais et al., 2016; Faraone, 
Biederman, & Mick, 2006). There are psychiatric and social comorbidities associated 
with ADHD; adults with ADHD are at increased risk of impairments in education and 
academic performance, serious traffic accidents, criminality and physical and mental 
health problems (Dalsgaard, Ostergaard, Leckman, Mortensen, & Pedersen, 2015; 
Ginsberg, Hirvikoski, & Lindefors, 2010; Ljung, Chen, Lichtenstein, & Larsson, 2014; 
Shaw-Zirt, Popali-Lehane, Chaplin, & Bergman, 2005; Spencer, Faraone, Tarko, 
McDermott, & Biederman, 2014). Pharmacological treatments are effective first-line 
treatments for ADHD (Cortese et al., 2018). However, up to half of patients discontinue 
medication within the first 3 years of treatment (Zetterqvist, Asherson, Halldner, 
Långström, & Larsson, 2013), with reported reasons being adverse effects and 
treatment ineffectiveness (Gajria et al., 2014). Recent guidelines produced by the UK 
National Institute for Health and Care Excellence (NICE) recommend that non-
pharmacological treatment be used in combination with medication for adults who are 
still experiencing significant symptoms or for those who have made the informed 
choice not to start medication (NICE, 2018). Recent evidence notes that cognitive-
behaviour-based treatments may be beneficial for adults with ADHD (Lopez et al., 
2018). However, other modalities of non-pharmacological treatment require further 
review, particularly whether improvements occur beyond the core symptoms of ADHD 
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such as in social functioning (Davidson, 2008; Hodgson, Hutchinson, & Denson, 
2014). This study aims to conduct a systematic review of the effectiveness of all non-
pharmacological treatments for adult ADHD on improving the core behavioural ADHD 
symptoms, symptoms of functional impairment and comorbid conditions.  
 
METHODS 
 
Inclusion and exclusion criteria 
 
Eligible studies included participants with ADHD or hyperkinetic disorder (HKD) 
diagnosed according to established diagnostic criteria (e.g., DSM-III-R, DSM-IV, DSM-
5, or ICD-10); with participants all aged 18 years or over; and reported the results of a 
non-pharmacological intervention. Studies were excluded if the primary intervention 
was being used as a medicine, including dietary supplementation and homeopathy. 
All studies were required to use randomisation to allocate participants to either the 
intervention or a control condition.  Control conditions included using a waiting list, 
treatment as usual, a pharmacological intervention, placebo, or an alternative non-
pharmacological intervention. Outcomes of interest were improvement in the core 
behavioural symptoms of ADHD (i.e., those outlined in DSM-III-R, DSM-IV or DSM-5), 
improvement in comorbid symptoms (for example anxiety and depression) and in 
symptoms of functional impairment (defined as problems in life domains such as 
work/education, family, life skills, social skills and/or risk-related behaviours). 
Neuropsychological, neurophysiological and neurobiological outcome measures were 
not examined since this was considered beyond the scope of this review and because 
behavioural rating scales are chiefly relied upon for the diagnosis and assessment of 
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ADHD in routine clinical practice (NICE, 2018) Studies were also excluded if they were 
not available in English.  
 
Search strategy 
 
The following databases were searched in May 2018: PsycINFO, MEDLINE (Ovid), 
EMBASE, CINAHL and CENTRAL. Search strategies for all databases are available 
in Supplement Table 1. Titles and abstracts were screened for eligibility by 
independent reviewers LS, SL and VN-S. In cases of uncertainty, the full articles were 
obtained and independently inspected, and inclusion criteria applied by the reviewers. 
Where meta-analysis or systematic reviews of treatment were available, we referred 
to the primary studies and assessed these for eligibility and reviewed the references 
of all included studies to identify any additional studies.   
 
 
Data extraction, assessment of bias and data analysis 
 
Data from the studies were extracted using a purpose-designed proforma 
(Supplement Table 2). The quality of studies was appraised using the Cochrane Risk 
of Bias Tool (Higgins et al., 2011) and, where there was uncertainty, clarification was 
sought from a second reviewer. Where information was not known the corresponding 
author for the studies was contacted. It was decided a-priori to undertake a narrative 
synthesis of the data should an insufficient number of studies be identified, and/or the 
identified studies be at high risk of bias, and/or the identified studies appear highly 
heterogeneous in terms of methodology and study characteristics.  
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RESULTS 
 
Search results 
 
The results of the initial search, title and abstract screening, and selection of the final 
studies are presented in Figure 1. The search string identified 55,865 articles, the 
majority of which were excluded following review of titles and abstracts. Of the 75 full-
text records screened for eligibility, 32 met inclusion criteria and were included in the 
systematic review. Two papers reported differing outcomes of the same trial, with the 
later paper presenting additional functional outcomes (S. Young et al., 2017; S. Young 
et al., 2015). Two papers reported the results of different comparison groups from 
within the same trial (Virta, Salakari, Antila, Chydenius, Partinen, Kaski, & Iivanainen, 
2010; Virta, Salakari, Antila, Chydenius, Partinen, Kaski, Vataja, et al., 2010). 
 
Risk of bias 
 
Results of the risk of bias assessment are presented in Table 1. Only one of the 
included records was assessed as having a low risk of bias across all five domains 
and that was for only one of the interventions within the trial (Schonenberg et al., 
2017), and nine records were assessed as having a low risk of bias in four out of five 
domains (Dittner, Hodsoll, Rimes, Russell, & Chalder, 2018; Gu, Xu, & Zhu, 2018; 
Janssen et al., 2018; Philipsen et al., 2015; Salomone et al., 2015; Stern, Malik, Pollak, 
Bonne, & Maeir, 2016; Vidal et al., 2013; S. Young et al., 2017; S. Young et al., 2015). 
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For a significant number of studies, it was not possible to assess the risk of bias in at 
least one of the five domains due to insufficient information. 
 
 
Study characteristics  
 
Study characteristics are presented in Table 2 (and results in supplement Table 3). 
The interventions fell into eight broad categories: 1. cognitive-behavioural therapy; 2. 
dialectical behavioural therapy; 3. mindfulness-based therapy; 4. hypnotherapy; 5. 
Psychoeducation; 6. neurofeedback; 7. cognitive remediation and other forms of “brain 
training”, and; 8. a study skills intervention. Studies were highly heterogeneous in 
terms of sample size, age range, and gender of the participants and outcome 
measures. Due to this heterogeneity, and the aforementioned risk of bias, a narrative 
synthesis of results was used.   
 
Narrative synthesis 
 
Cognitive behavioural therapy (CBT) 
 
There were fourteen randomised controlled trials of CBT and one additional study 
presenting outcomes of further results from an earlier study (S. Young et al., 2017). 
Details of CBT interventions are in Table 3 and supplement Table 4. None of the CBT 
studies were assessed as having a low risk of bias across all five domains and there 
was substantial variation in sample size across studies. 
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Five studies compared CBT with treatment as usual (TAU) (Dittner et al., 2018; 
Emilsson et al., 2011; Safren et al., 2005; S. Young et al., 2017; S. Young et al., 2015) 
CBT produced an improvement in independent and self-reported ADHD symptoms, 
both for group (Emilsson et al., 2011; S. Young et al., 2015) and individual (Dittner et 
al., 2018; Safren et al., 2005) therapy. Improvements included changes in inattentive 
and hyperactive-impulsive symptoms and were based on measures taken at pre and 
post-treatment and at follow-up. Three studies also reported lower Clinical Global 
Impression (CGI) scores following CBT (Dittner et al., 2018; Safren et al., 2005; S. 
Young et al., 2015). These results indicate a favourable effect of CBT compared to 
TAU. However, all studies had a high risk of bias associated with blinding as 
participants in the treatment arms received more attention than controls.  
 
Three studies compared CBT to a form of generic counselling. The studies ranged in 
sample size from 32 (Vidal et al., 2013) to 433 (Philipsen et al., 2015). In two studies, 
both CBT and counselling were associated with improvements in ADHD symptoms; 
however there was no evidence that CBT led to greater improvements in either 
informant or self-reported ADHD (Philipsen et al., 2015; Vidal et al., 2013) and only 
one study found CBT improved CGI scores (Philipsen et al., 2015). The largest study 
was Philipsen et al (n= 433); however, it is limited by comparing group CBT with 
individual supportive clinical management and so arguably the control group received 
a more intensive treatment (Philipsen et al., 2015). In addition to this, the program 
manual followed in this study had more similarities with the DBT treatment described 
in a later study than other CBT studies (Table 3 and supplement Table 4) (Hesslinger, 
Philipsen, & Richter, 2004; Hirvikoski et al., 2011).   
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One study examined the impact of CBT on a “younger” (aged under 50) and “older” 
(aged 50 or older) group of patients with ADHD (Mary V Solanto, Surman, & Alvir, 
2018). This found improvements in ADHD symptoms on both independent and self-
reported measures in the “younger” group, but not the “older” group.  
 
 
One study compared CBT to relaxation training (Safren et al., 2010). CBT was 
associated with greater improvements in independent ratings of ADHD symptoms and 
in clinician-rated CGI scores. CBT also led to quicker improvements in self-reported 
ADHD symptoms. Improvements were maintained at six and twelve-month follow-up. 
Two studies explored the use of internet-delivered CBT versus a waiting list control 
(Moëll, Kollberg, Nasri, Lindefors, & Kaldo, 2015; Pettersson, Sostrom, Edlund-
Soderstrom, & Nilsson, 2017). Both studies found that, CBT was associated with 
significant improvements in self-reported ADHD symptoms.  
 
Two studies examined meta-cognitive therapy, a form of CBT based on improving 
executive functioning skills. Group meta-cognitive therapy was associated with greater 
changes in clinician and informant ratings of inattentive ADHD symptoms and clinician 
ratings of time-management, organisation and planning skills when compared with 
group supportive therapy, although both CBT and supportive therapy were associated 
with changes in ADHD symptoms rated using the Brown Attention Deficit Disorder 
Scale (M. V. Solanto et al., 2010). One study compared individual meta-cognitive 
therapy with neurofeedback and sham neurofeedback, and found no significant 
difference between treatment groups for changes in self-reported ADHD symptoms 
(Schonenberg et al., 2017). 
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Two studies used the same sample to compare CBT with cognitive training, 
hypnotherapy and a control condition (Hiltunen et al., 2014; Virta, Salakari, Antila, 
Chydenius, Partinen, Kaski, Vataja, et al., 2010). CBT was associated with an 
improvement in one informant-rated measure of ADHD symptoms when compared to 
the control condition (Virta, Salakari, Antila, Chydenius, Partinen, Kaski, Vataja, et al., 
2010). There were no differences between CBT and cognitive training based on 
informant or self-reported ADHD symptoms but CBT was associated with lower CGI 
scores. Compared with hypnotherapy, CBT produced no significantly different 
changes in informant or self-reported ADHD symptoms or CGI scores post-treatment. 
However, at follow-up, hypnotherapy but not CBT was associated with a change in 
informant ratings of ADHD (Hiltunen et al., 2014). These studies were particularly 
small with 10 or less individuals in each treatment group.  
 
 
Dialectical behavioural therapy (DBT) 
 
Two randomised controlled trials assessed group DBT. Details are presented in Table 
3 and supplement Table 4. One (Hirvikoski et al., 2011) compared 14 sessions of DBT 
with a discussion group. DBT, but not the discussion group, was associated with a 
significant reduction in self-ratings of ADHD symptoms; however this difference was 
attenuated to a non-significant level when an intention-to-treat analysis was 
performed. This study was associated with a low risk of bias. The second study 
(Fleming, McMahon, Moran, Peterson, & Dreessen, 2015) compared DBT to self-help 
and was associated with a higher risk of bias. Those who received DBT performed 
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significantly better on measures of the clinical impact of executive functioning deficits 
after treatment and at three-month follow-up; however there was no significant effect 
of the intervention on self-rated symptoms of inattention.  
 
 
Mindfulness-based interventions  
 
Four studies examined mindfulness-based cognitive therapy (MBCT), an intervention 
that combines elements of mindfulness training with CBT, while two additional studies 
examined mindfulness interventions. These studies varied in terms of sample size and 
risk of bias, with none rated as low risk of bias for the blinding of participants. Details 
are presented in Table 4 and supplement Table 5. 
 
Compared to TAU, group MCBT was associated with a significant improvement in 
post-treatment observer and self-reported ADHD symptoms and with improved 
behavioural ratings of executive functioning at three and six-month follow-up but not 
immediately after treatment (Janssen et al., 2018). Two further studies, which 
compared group MBCT to a waiting list control, found significant improvements in 
ADHD symptoms post treatment for self-reported (Hepark et al., 2019; Schoenberg et 
al., 2014) and observer-reported (Hepark et al., 2019) ADHD symptoms immediately 
after the intervention but did not collect follow-up data. A fourth study compared 
individual MBCT to a waiting list control and found an improvement in self-reported 
ADHD symptoms at post-treatment and at follow-up (Gu et al., 2018). 
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Compared to an active control of group psychoeducation, group mindfulness did not 
produce a significant improvement in observer or self-reported ADHD symptoms either 
post-treatment or at six-month follow-up (Hoxhaj et al., 2018). However, it was noted 
that both interventions appeared to improve outcomes. A smaller study found that 
group mindfulness sessions produced a significant improvement in self- and observer-
reported ADHD symptoms, however this was versus a waiting list control and had had 
high risk of bias (Mitchell et al., 2017).       
 
Hypnotherapy 
 
Hypnotherapy as a treatment for ADHD has been studied in two small RCTs, both of 
which were associated with a high risk of bias. Details are provided in Table 4 and 
supplement Table 5. One study compared hypnotherapy with CBT, the results of which 
are described above (Hiltunen et al., 2014). Another study (Virta, Salakari, Antila, 
Chydenius, Partinen, Kaski, & Iivanainen, 2010) compared the same participants to 
those receiving no intervention, finding that those in the ADHD group scored 
significantly lower for self-reported total ADHD scores and some subscales of the 
BADDS scale; however, there was no significant improvement in ADHD symptoms 
over time based on aggregate self and informant ratings of ADHD.  
 
Psychoeducation 
Group psychoeducation was measured as the primary intervention versus a TAU 
control in one study by Hirvikoski et al (n = 87) and in comparison to mindfulness-
based cognitive therapy by Hoxhaj et al (n = 81). Both studies had a low risk of bias in 
three out of the five domains.  Hirvikoski et al assessed the feasibility and effectiveness 
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of a group-based psychoeducation programme for people with ADHD and their 
significant others (Hirvikoski et al., 2017). ADHD behavioural symptoms were not 
measured and no significant differences were found in secondary outcomes of 
functional impairment (reported in supplement Table 3). Hoxhaj et al found no 
difference between the psychoeducation group and mindfulness group in observer or 
self-reported ADHD symptoms (see above)(Hoxhaj et al., 2018). 
   
Neurofeedback 
One randomised controlled trial compared neurofeedback with both sham 
neurofeedback and meta-cognitive therapy as control interventions (Schonenberg et 
al., 2017). This study was assessed as low risk of bias in all five domains, as the 
sham neurofeedback provided an effective control condition.  There were no 
significant differences between neurofeedback, sham neurofeedback and 
metacognitive therapy for improvement in ADHD symptoms after treatment or at six-
month follow-up.   
 
Cognitive remediation and rehabilitation 
 
Seven studies sought to improve both the behavioural symptoms and the 
neurocognitive functioning of people with ADHD using methods such as cognitive 
remediation, rehabilitation or another form of “brain training”. Details of these 
interventions are given in Table 4 and supplement Table 5. Two studies examined 
therapist-delivered (C. S. Stevenson, Whitmont, Bornholt, Livesey, & Stevenson, 
2002) and self-directed (Caroline S Stevenson, Stevenson, & Whitmont, 2003) 
cognitive remediation. Four studies examined computerised cognitive training 
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(Mawjee et al., 2017; Mawjee, Woltering, & Tannock, 2015; Stern et al., 2016; Virta, 
Salakari, Antila, Chydenius, Partinen, Kaski, Vataja, et al., 2010), with two focussing 
on working memory training (Mawjee et al., 2017; Mawjee et al., 2015). Finally, one 
study examined self-alert training (Salomone et al., 2015). Only two of the studies were 
assessed as having low risk of bias in only one of the five domains (Salomone et al., 
2015; Stern et al., 2016), with the remainder having a high risk of bias or unknown risk 
of bias in at least two domains. 
 
Therapist delivered cognitive remediation produced a significant improvement in 
ADHD symptoms and in organisation skills, which were maintained at two and 12-
month follow-up. These findings remained after controlling for ADHD medication. (C. 
S. Stevenson et al., 2002). Self-directed cognitive remediation augmented with three 
therapist-led sessions also significantly improved ADHD symptoms and organisation 
post-intervention and at two-month follow-up (Caroline S Stevenson et al., 2003).  
 
Two studies of working memory training consisting of standard (45 minutes of daily 
training), or a shortened (15 minute training), found no significant improvement in 
measures of ADHD symptoms or self-reported measures of deficits in executive 
function with either form of working memory training versus a waiting list control 
(Mawjee et al., 2017; Mawjee et al., 2015).  However Mawjee et al 2017 found on post-
hoc analysis that although self-reported symptoms of cognitive failures did not differ 
between shortened and standard length training and the control group, there was a 
significant difference when both forms of working memory training were compared 
together against the control. This study had limited power due to having a small sample 
size (n = 38).        
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The study comparing cognitive training versus a CBT and control group in a group of 
32 individuals has been described above, noting that there was no significant 
difference in improvement in ADHD symptoms (Virta, Salakari, Antila, Chydenius, 
Partinen, Kaski, Vataja, et al., 2010).  A larger study of 60 individuals comparing 
computerised cognitive training versus a control condition of generic exercises found 
no difference between the intervention and control on improvement in ADHD 
symptoms (Stern et al., 2016).   
 
Self-alert training using biofeedback scored significantly lower post-intervention and 
at three-month follow-up for symptoms of inattention, impulsivity and emotional lability, 
for problems with self-concept, and for the ADHD index score compared with a control 
condition which used all aspects of the treatment except the use of biofeedback 
(Salomone et al., 2015). In contrast, there were no significant group differences for 
scores on the attention and memory problems scale, the hyperactivity and 
restlessness scale, the DSM-IV hyperactive symptoms scale, or the DSM-IV total 
symptoms scale.  There was evidence of a treatment dose-response effect, whereby 
longer self-alert training practice was associated with greater reductions in inattentive 
symptoms of ADHD, but not to changes in other ADHD symptom domains. 
Participants in the training group reported significantly lower ratings for attentional slips 
than controls, but with no group differences for lapses in memory.  
 
Study skills intervention and self-monitoring  
There was one study which specifically explored a “study skills intervention” 
compared to a control condition (Scheithauer & Kelley, 2017). The details of this are 
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described in more detail in Table 4 and supplement Table 5. Significantly more 
individuals in the self-monitoring group versus the control group demonstrated 
clinical improvements in self-reported symptoms of ADHD. However, this study was 
noted to be of high-risk for bias.  
  
Functional Impairment 
Symptoms of psychiatric comorbidity and/or functional impairment were also 
examined in this review, with results summarised in supplement Table 3. In summary, 
of the 14 CBT studies (including one follow-up study) measuring comorbidity or 
functional outcomes, six found a positive result for CBT in at least one measure of 
these outcomes (Dittner et al., 2018; Emilsson et al., 2011; Moëll et al., 2015; Safren 
et al., 2005; S. Young et al., 2017; S. Young et al., 2015).  One of the two DBT studies 
and one of the two hypnotherapy studies measuring comorbidity or functional 
outcomes found a significantly improved outcome in at least one measure favouring 
the intervention (Fleming et al., 2015; Hiltunen et al., 2014). None of the studies of 
psychoeducation or neurofeedback found a significant difference for measures of 
these outcomes. Seven of the cognitive remediation studies measured comorbidity 
and/or functional impairment, with four finding a statistically significant result in at least 
one measure (Mawjee et al., 2017; Salomone et al., 2015; Caroline S Stevenson et 
al., 2003; C. S. Stevenson et al., 2002).  Self-monitoring was associated with 
significantly improved functional outcomes relating to academic studies (Scheithauer 
& Kelley, 2017). Four of the six mindfulness-based intervention studies found 
significant improvements in measures of comorbidity, favouring the intervention, but 
none of the studies found significant improvements in functional outcomes (Gu et al., 
2018; Janssen et al., 2018; Mitchell et al., 2017; Schoenberg et al., 2014).   
 19 
 
 
DISCUSSION  
 
This systematic review examined the effectiveness of non-pharmacological 
interventions for adult ADHD. These studies used a wide range of outcome measures 
and most of the identified studies were small (<60 randomised participants)  
and at a high risk of bias, with marked heterogeneity in terms of study design and 
delivery of the intervention. A meta-analysis was therefore considered inappropriate 
and these limitations impact on the extent to which firm conclusions can be drawn. 
 
 
The results across studies suggest that non-pharmacological interventions perform 
significantly better than inactive control conditions when used to manage the core 
behavioural symptoms of ADHD. Studies with an active control condition gave more 
mixed results as often there was a significant within-group improvement in the control 
condition, which could be due to placebo effect or another aspect of the control 
condition providing an active treatment element, such as increasing patient 
knowledge, and motivation for engagement (Hoxhaj et al., 2018; Vidal et al., 2013), or 
through task demands such as practicing sustaining focus (Schonenberg et al., 2017), 
or through providing a therapeutic relationship (Philipsen et al., 2015). Nonetheless, 
these findings suggest that non-pharmacological interventions can play an important 
role in helping adults diagnosed with ADHD to manage their condition. 
 
By far the greatest number of studies (n=14) examined cognitive behavioural therapy 
(CBT). The results of these studies broadly suggest that CBT is associated with a 
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reduction in the core behavioural symptoms of ADHD and can be delivered as either 
a group, individual or internet-based form of therapy. However, there was marked 
heterogeneity across studies, both in terms of sample size, study design and quality, 
and in terms of the kind of change in ADHD symptoms identified. For example, some 
studies found a reduction in informant but not self-reported ADHD symptoms and vice-
versa; some identified lasting change in ADHD symptoms based on follow-up data but 
not immediately after the intervention and some studies failed to find any benefit of 
CBT over and above an active control condition. Further research into CBT 
interventions is therefore required, including studies that seek to replicate the 
promising results identified thus far. 
 
Some other interventions also showed promise, in particular cognitive remediation and 
rehabilitation, mindfulness-based therapies and to some extent DBT and 
hypnotherapy. Both MBCT and DBT are similar to CBT in that they support people to 
change their behaviours, and indeed there are many parallels across all of the different 
classes of intervention identified in this study.  However, MBCT and DBT are 
considered “third-wave” cognitive and behavioural therapies and differ from traditional 
CBT in that they help individuals to change the relationship with their thoughts as 
opposed to directly challenging the content of thoughts (Hayes & Hofmann, 2017). 
MCBT and DBT both also teach mindful awareness as a therapeutic technique, which 
involves gently redirecting attention to the present moment when it wanders. It is 
possible that this acts as a form of brain training, highlighting parallels between these 
interventions and cognitive remediation therapy, which also involves attention training 
and was associated with a reduction in the core symptoms of ADHD.  
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Symptoms of functional impairment and comorbidity were also examined in this 
review. There was a wide variation in results, with the most consistent effect of therapy 
being the impact of mindfulness-based therapies on psychiatric comorbidity, which is 
consistent with the use of mindfulness-based therapies on treating anxiety and 
depression (Hofmann, Sawyer, Witt, & Oh, 2010). Whilst studies reporting on 
comorbidity and functional outcomes were likely to be powered primarily to detect a 
change in behavioural symptoms of ADHD and not to detect changes in comorbidity, 
there is the potential for non-pharmacological interventions to improve quality of life 
for adults with ADHD in a much broader sense, and this is an area that should be 
explored further in future research.  
 
There were a wide number of measures used for ADHD symptoms, comorbidity and 
functional impairment. This contributed to the heterogeneity of the results and difficulty 
in making comparisons between treatment approaches. Because of this, it seems 
important to recommend that future research takes a systematic approach. First, a set 
of core outcome measures could be established, including both observer and self-
reported ratings of ADHD symptoms in accordance with diagnostic criteria. A set of 
core outcome measures could include measures of psychological distress, such as 
Beck’s inventories for anxiety and depression (Beck & Steer, 1990; Beck, Steer, & 
Brown, 1996) and a scale of functional impairment such as the adult attention-deficit 
hyperactive disorder quality-of-life scale (AAQOL Scale) (Brod, Johnston, Able, & 
Swindle, 2006). Importantly, these should be developed in consultation with the adult 
ADHD community in order to ensure that ‘real life’ outcomes that matter to individuals 
are included in future trials. 
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Secondly, where there have been studies of non-pharmacological interventions that 
have shown promise, we need larger, better designed trials. Trials with a low risk of 
bias should ensure that allocation concealment occurs and that outcomes are 
assessed by independent, blinded assessors. Trials should aim to be powered to 
detect not only effects of treatment on the behavioural symptoms of ADHD, but also 
symptoms of comorbidity. Trials should also directly compare non-pharmacological 
interventions for ADHD with pharmacotherapy. This form of comparison was rarely 
undertaken, yet the right of adults with ADHD to make an informed choice about 
interventions sits at the heart of patient-centred care. One large study included in this 
review did compare non-pharmacological interventions to medication and in doing so 
found that methylphenidate had the greatest effect on ADHD regardless of the non-
pharmacological intervention used (Philipsen et al., 2015). 
 
Thirdly, and to help identify the ‘active ingredients’ of treatment, studies could begin to 
look at mediating variables to find out what leads to a change in symptoms following 
non-pharmacological treatment. In CBT, for example, it is not clear whether psycho-
education, problem-solving, cognitive restructuring, behavioural change or a 
combination thereof, leads directly or indirectly to a change in ADHD or comorbid 
symptoms. Mediators may also include neurobiological, neurophysiological or 
neuropsychological performance, particularly as these variables are considered to be 
‘endophenotypes’ of ADHD (Castellanos & Tannock, 2002) that may bridge the gap 
between genes and behaviours.  
 
This review should be interpreted in the context of several limitations. First, the 
review was not pre-registered. Secondly, although much effort was made to retrieve 
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a maximum number of relevant studies, we cannot rule out the possibility that we 
have missed some relevant studies. For example, we only included published papers 
did not search the grey literature. We also focused on English-language publications 
due to  resource limitations. This could have possibly introduced a cultural bias in 
terms of the kinds of interventions reported and may limit the extent to which findings 
generalise to different countries and cultures.  Thirdly, due to heterogeneity and risk 
of bias across the identified studies, it was not possible to conduct a meta-analysis; 
therefore, the effect sizes across different studies were not examined. This makes it 
difficult to draw any direct comparisons between the different classes of intervention.  
Finally, many of the interventions described take similar approaches, meaning that 
the different classes of intervention have much in common.  
 
Despite these limitations this review serves as a bellwether, identifying the state of 
research into non-pharmacological interventions for adult ADHD and highlighting 
their potential in clinical practice, and identifying gaps in the evidence with 
suggestions about the direction of future research.   
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 Table 1: Risk of bias assessment for randomised controlled trials of non-
pharmacological interventions for adult ADHD 
Author (Year) Number of 
participant
s. 
Assessment of Bias 
Selection 
Bias 
Allocation 
concealmen
t 
Blinding of 
participants 
Blinding of 
outcome 
assessment 
Incomplete 
outcome 
data 
Dittner et al (2018) 60 Low Low High Low Low 
Emilsson et al (2011)  54  Unclear Low High  Low High  
Fleming  
et al (2015) 
35  
 
Unclear Unclear High Low 
 
Low 
Gu et al (2018) 56 Low Low High Low Low 
Hepark et al (2019) 103 Unclear Low  High Low Low 
Hiltunen et al  (2014) 39  Unclear Unclear High Low Low 
Hirvikoski et al 
(2017) 
87 Low Low High High Low 
Hirvikoski et al 
(2011)  
51  Low Low High High Low 
Hoxhaj et al (2018) 81 Low Low Unclear Low Unclear  
Janssen et al (2018) 120 Low Low High Low Low 
Mawjee et al (2017) 38 Low Low High Low High 
Mawjee et al (2015)  97  Low Low High High Lowa 
Mitchell et al (2017) 22 Unclear Unclear High High Low 
Moëll et al (2015) 57 Unclear Unclear High Low Low 
Pettersson et al 
(2017) 
45 Low Low High Low High 
Philipsen et al (2015)  433  Low Low High Low Low 
Safren et al (2010)  86  Low Unclear High  Low Unclear 
Safren  et al (2005)  31  Unclear Unclear High Low Low 
Salomone et al 
(2015)  
51  Low Low Low Low High 
Scheithauer and 
Kelley (2017) 
52 Low High High High High 
Schoenberg et al 
(2014)  
61  Low High High  Low Low 
Schönenberg et al 
(2017) 
118 
Neurofeedb
ack 
Low Low Low Low Low 
Meta-
cognitive 
therapy 
Low Low High High Low 
Solanto et al (2018) 88 Low Unclear Unclear Low Unclear 
Solanto, et al (2010)  88  Unclear Unclear Unclear Low Low 
Stern et al (2016) 60 Low Low Low Low High 
Stevenson et al 
(2003)  
35 Unclear Unclear High Unclear Low 
Stevenson et al 
(2002)  
44  Unclear Unclear High Unclear Lowa 
Vidal et al (2013)  32  Low Low High Low Low 
Virta et al. (2010)  20 Unclear Unclear High Low Low 
Virta et al. (2010)  32 Unclear Unclear High Low Low 
Young et al (2017) 95  Low Low High Low Low 
Young et al (2015)  95  Low Low High Low Low 
aThis refers to times T1 and T2 only as we cannot use time T3 as there is not a suitable control group. 
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Table 2: Overview of non-pharmacological intervention sample characteristics, 
outcome measures and results 
 
Author (Year) n  Intervention Control Sample characteristics 
Mean age % female 
Individual CBT  
Dittner et al (2018) 60 Individual CBT TAU 36 (CBT)  
36 (TAU) 
23 (CBT) 
40 (TAU) 
Safren et al (2010)  86  Individual CBT 
 
Individual Relaxation 42 (CBT) 
44 (Relaxation) 
44 (CBT) 
44 (Relaxation) 
Safren  et al (2005)  31  Individual CBT TAU 46 55 
Virta et al. (2010)  32 Individual CBT  Control group (not 
specified) 
38 (CBT) 
32 (CT) 
34 (Control) 
70 (CBT) 
22 (CT) 
60 (Control) 
Cognitive training 
(CT) 
Hiltunen et al  (2014) Study described below under “hypnotherapy”  
Group CBT and group meta-cognitive therapy 
Emilsson et al 
(2011)  
54  Group CBT and 
medication 
TAU and medication 34 63 
Philipsen et al 
(2015)  
433  Group CBT + 
methylphenidate 
(MPT) 
Clinical Management 
individual counselling 
(CM) + MPT 
35 (DBT+ MPT) 
35 (DBT + 
placebo) 
35 (CM + MPT) 
35 (CM + 
placebo)  
49 (DBT + MPT) 
42 (DBT+ 
placebo) 
46 (CM+ MPT) 
55 (CM + 
placebo) 
Group CBT + placebo CM + Placebo 
Schönenberg et al (2017) Study described below under “neurofeedback” 
Solanto 
et al 
(2018)  
 
27 (older group) Group CBT  Supportive therapy  56   63 
61 (younger 
group) 
35 67 
Solanto et al (2010) 88 Group Meta-
cognitive therapy 
(MCT) 
Supportive therapy  41 (MCT) 
42 (Control) 
71 (MCT) 
61 (Control) 
Vidal et al (2013)  32  Group CBT Psychoeducation group 
(PG) 
39 (CBT) 
40 (PG) 
40 (CBT) 
65 (PG) 
Young et al (2017)  95  
 
Group CBT and 
individual mentor 
meetings 
TAU 34 (CBT) 
36 (TAU) 
63 (CBT) 
68 (TAU) 
Young et al (2015) 
Internet CBT 
Moëll et al (2015) 57 Internet CBT (CBTi) WL 36 (CBTi) 
37 (WL) 
76 (CBTi) 
61 (WL) 
Pettersson et al 
(2017) 
45 Internet CBT with group 
sessions (CBTi-Group) 
WL 40 (CBTi- Group)  
39 (CBTi- SELF) 
34 (WL) 
  
57 (CBTi- Group)  
54 (CBTi- SELF) 
78 (WL) 
 
Internet CBT with self-
help (CBTi-SELF) 
DBT 
Fleming  
et al (2015) 
35  
 
Group DBT Self-help skills handouts 21 (DBT) 
21 (Control) 
41 (DBT) 
44 (Control) 
Hirvikoski et al 
(2011)  
51  Group DBT Discussion group  41 (DBT)  
37 (Control) 
73 (DBT) 
52(Control) 
Mindfulness-Based Cognitive Therapy (MBCT) and mindfulness 
Gu et al (2018) 56 Individual MBCT WL 20 (MBCT)  
20 (WL) 
43 (MBCT) 
46 (WL) 
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Hepark et al (2019) 103 Group MBCT WL 37 (MBCT) 
35 (WL) 
62 (MBCT) 
46 (WL) 
Hoxhaj et al (2018) 81 Mindfulness Group 
(MG) 
Psychoeducation Group 
(PG) 
41 (MG) 
39 (PG) 
56 (MG) 
48 (PG) 
Janssen et al (2018) 120 Group MBCT TAU 40(MBCT)  
39 (TAU) 
53 (MBCT)  
53 (TAU) 
Mitchell et al 
(2017) 
22 Mindfulness Group 
(MG) 
WL 41 (MG) 
36 (WL) 
55 (MG) 
67 (WL) 
Schoenberg et al 
(2014) 
61  MBCT WL 40 (MBCT) 
34 (WL) 
63 (MBCT) 
40 (WL) 
Hypnotherapy 
Hiltunen et al  
(2014) (a follow-up 
of Virta et al 2010) 
19  Group Hypnotherapy 
(GH) 
Individual CBT 39 (GH)  
32 (CBT) 
63 (GH) 
67 (CBT) 
Virta et al. (2010)  20 Hypnotherapy  Control group (not 
specified) 
34 (Treatment) 
34 (Control) 
67 (Treatment) 
60 (Control) 
Psychoeducation 
Hirvikoski et al 
(2017) 
87 Psychoeducation 
Group (PG) 
TAU  39 (PG) 
38 (TAU) 
65 (PG) 
54 (TAU) 
Hoxhaj et al (2018) Study discussed under “Mindfulness-Based cognitive therapies” above. 
Neurofeedback  
Schönenberg et al 
(2017) 
118 Neurofeedback 
(NEURO) 
Sham neurofeedback 
(SHAM) 
40 (NEURO) 
38 (CBT) 
36 (SHAM)  
49 (NEURO) 
42 (CBT) 
39 (SHAM) Group CBT 
Cognitive remediation and rehabilitation 
Mawjee et al 
(2017) 
38 Standard Working Memory 
Training (STAN) 
WL 24 (STAN) 
21 (SHORT) 
23 (Control) 
44 (STAN) 
38 (SHORT) 
58 (Control) 
Shortened Working Memory 
Training (SHORT) 
Mawjee et al 
(2015)  
97  Standard Working Memory 
Training (STAN) 
WL 24 (STAN) 
24 (SHORT) 
24 (Control) 
59 (STAN) 
64 (SHORT) 
56 (Control) Shortened Working Memory 
Training (SHORT) 
Salomone et al 
(2015)  
51  Self-alert training 
group and practice 
(SAT)  
Psychoeducation group 
and exercises (PG) 
33 (SAT) 
32 (PG) 
33 (SAT) 
26 (PG) 
Stern et al (2016) 60 Computerised 
Cognitive Training, 
focussing on 
executive function  
Generic computerised 
cognitive exercises which 
do not focus on 
executive function 
38 (Treatment) 
36 (Control) 
56 (Treatment) 
58 (Control) 
Stevenson et al 
(2003)  
35 “Self-help” strategy 
training 
WL 39 (Self-help) 
38 (WL) 
41 (Self-help) 
33 (WL) 
Stevenson et al 
(2002)  
44  Cognitive-remediation 
therapy  
WL 36 (Treatment) 
35 WL 
27 (Treatment) 
38 WL 
Virta et al. (2010) Study described above under “CBT”. 
Study skills intervention and self-monitoring 
Scheithauer and 
Kelley (2017) 
52 Self-monitoring and 
study skills 
intervention  
Study skills intervention  20 76 
CBT= Cognitive behavioural therapy; DBT= Dialectical Behavioural Therapy; MBCT= Mindfulness Based 
Cognitive Therapy; TAU= Treatment as usual; WL= Waiting list 
 27 
 
Table 3: Duration and details of cognitive behavioural- based interventions and 
dialectical behavioural therapy 
Author 
(Year) 
Intervention Duration of Cognitive Intervention 
Dittner et al 
(2018) 
Individual CBT 15 CBT sessions over 30 weeks and a 16th follow-up session at 42 weeks 
Emilsson et 
al (2011)  
Group CBT  15 weekly sessions of 90 minutes group “R&R2ADHD” CBT (SJ Young & Ross, 2007) 
and 30 minutes of individual coaching 
Fleming  
et al (2015) 
Group DBT 8 weekly 90 minute group sessions and weekly one-to-one phone calls for coaching 
with one booster session during the first week of the follow-up quarter 
Gu et al 
(2018) 
Individual MBCT 6 weekly 1 hour individual MBCT sessions 
Hepark et al 
(2019) 
Group MBCT 12 weekly sessions  
Hirvikoski et 
al (2011)  
Group DBT 14 weekly 2 hour group sessions  
Janssen et al 
(2018) 
Group MBCT 8 weekly 2.5 hour sessions and a 6 hour silent day between the 6th and 7th sessions  
Moëll et al 
(2015) 
Internet CBT 
(CBTi) 
7 modules over 6 weeks 
Pettersson et 
al (2017) 
Internet CBT 
with self-help  
9 CBT treatment modules and a follow-up module  
Internet CBT 
with group 
sessions   
9 CBT treatment modules and a follow-up module 
Group sessions met for 3hours once a week for 10 weeks 
Philipsen et 
al (2015) 
Group therapy, 
using aspects of 
a DBT based 
method 
(Hesslinger et 
al., 2004) 
12 weekly 2 hour DBT sessions followed by 10 monthly 2 hour sessions over 52 
weeks 
 
Each session was split into 2 with each half starting with a mindfulness exercise 
Safren et al 
(2010)  
Individual CBT 
 
12 weekly 50 minute sessions of CBT 
Safren  et al 
(2005)  
Individual CBT 15 weekly sessions of CBT 
Schoenberg 
et al (2014) 
MBCT 12 weekly 3 hour sessions of MBCT 
Schönenberg 
et al (2017) 
Group CBT, 
compared with 
Neurofeedback 
12 weekly group CBT sessions  
Solanto, et al 
(2018)  
Group CBT 12 weekly 2 hour group CBT sessions 
Solanto, et al 
(2010) 
Group Meta-
cognitive 
therapy (MCT) 
12 weekly 2 hour group MCT sessions 
Vidal et al 
(2013)  
Group CBT 12 weekly 2 hour sessions of group CBT 
Virta et al. 
(2010) 
Individual CBT 
(compared with 
cognitive 
training) 
10 weekly 1 hour individualised CBT sessions 
Young et al 
(2017) and 
Young et al 
(2015) 
Group CBT and 
individual 
mentor 
meetings 
15 weekly sessions of 90 minutes group “R&R2ADHD” CBT and individual coaching 
in-between sessions 
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Table 4: Duration and details of all other interventions 
 
  
Author 
(Year) 
Duration of intervention 
Hiltunen et al  
(2014) and 
Virta et al 
(2010) 
10 weekly sessions of group hypnotherapy 
Hirvikoski et 
al (2017) 
8 session psychoeducation group 
Hoxhaj et al 
(2018) 
8 weekly 2.5 hour group mindfulness sessions and daily meditation homework 
8 weekly 2.5 hour psychoeducation group sessions  
Mawjee et al 
(2017) and 
Mawjee et al 
(2015) 
Standard Working Memory Training 
25 training sessions (lasting 45 minutes) over 5-6 weeks  
Shortened Working Memory Training 25 training sessions (lasting 15 minutes) over 5 
weeks 
Mitchell et al 
(2017) 
8 weekly 2.5 hour group mindfulness sessions and daily meditation homework 
Salomone et 
al (2015)  
Self-alert training groups and 5 weeks of home practice exercises, lasting 30 minutes 
a day 
Scheithauer  
and Kelley 
(2017) 
One Self-monitoring and study skills teaching intervention with self-monitoring 
lasting 4-6 weeks 
Schönenberg 
et al (2017) 
30 group neurofeedback training sessions over 15 weeks  
Stern et al 
(2016) 
12 weeks of 4-5 times a week 20-minute-long online cognitive training sessions 
Stevenson et 
al (2003)  
8 week intervention of “self-help” strategy training   
Stevenson et 
al (2002)  
8 weekly 2 hour group sessions  
Virta et al. 
(2010) 
20 twice weekly hourly computerised cognitive training sessions  
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